SciSparc Ltd. (SPRC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SciSparc Ltd., in collaboration with Clearmind Medicine, has published encouraging study results showing the potential of their combined therapy with MEAI for weight loss. The treatment, aimed at obesity and metabolic syndrome, demonstrated significant weight reduction and improved glucose metabolism in mice without increasing food intake. This scientific breakthrough indicates a promising future for safer and more effective obesity treatments based on the synergy of SciSparc’s and Clearmind’s proprietary compounds.
For further insights into SPRC stock, check out TipRanks’ Stock Analysis page.